TrialClinical pharmacology and therapeutics2025

Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease.

Antoinette Ajavon-Hartmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.